Acquired immunodeficiency syndrome-related lymphoma: simultaneous treatment with combined cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy and highly active antiretroviral therapy is safe and improves survival--results of the (Q82665464)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 April 2006

Language	Label	Description	Also known as
English	Acquired immunodeficiency syndrome-related lymphoma: simultaneous treatment with combined cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy and highly active antiretroviral therapy is safe and improves survival--results of the	scientific article published on 01 April 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16502436%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Acquired immunodeficiency syndrome-related lymphoma: simultaneous treatment with combined cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy and highly active antiretroviral therapy is safe and improves survival--results of the German Multicenter Trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16502436%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

based on heuristic

inferred from title

author name string

Rudolf Weiss

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16502436%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Paris Mitrou

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16502436%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Keikawus Arasteh

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16502436%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Dirk Schuermann

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16502436%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Marcus Hentrich

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16502436%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Ulrich Duehrsen

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16502436%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Hinrich Sudeck

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16502436%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Ingo G H Schmidt-Wolf

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16502436%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Ioannis Anagnostopoulos

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16502436%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Dieter Huhn

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16502436%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

1 April 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16502436%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16502436%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

106

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16502436%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16502436%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1560-1568

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16502436%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Impact of HAART on the clinical management of AIDS-related cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21759

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of concomitant antiblastic chemotherapy and highly active antiretroviral therapy on human immunodeficiency virus (HIV) viremia and genotyping in HIV-infected patients with non-Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21759

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21759

7 January 2021

based on heuristic

inferred from DOI database lookup

Systemic non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21759

7 January 2021

based on heuristic

inferred from DOI database lookup

Advances in the epidemiology of HIV-associated non-Hodgkin's lymphoma and other lymphoid neoplasms

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21759

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort study. Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21759

7 January 2021

based on heuristic

inferred from DOI database lookup

Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21759

7 January 2021

based on heuristic

inferred from DOI database lookup

AIDS and cancer in the era of highly active antiretroviral therapy (HAART).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21759

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21759

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of highly active antiretroviral therapy on survival among HIV-infected men with Kaposi sarcoma or non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21759

7 January 2021

based on heuristic

inferred from DOI database lookup

AIDS-related malignancies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21759

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment options of AIDS-related lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21759

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21759

7 January 2021

based on heuristic

inferred from DOI database lookup

Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21759

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group Trial (E1494).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21759

7 January 2021

based on heuristic

inferred from DOI database lookup

Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21759

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of radiation therapy in the management of the non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21759

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical stage 1 non-Hodgkin's lymphoma: long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21759

7 January 2021

based on heuristic

inferred from DOI database lookup

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21759

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV-related non-Hodgkin's lymphoma: CHOP induction therapy and interferon-alpha-2b/zidovudine maintenance therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21759

7 January 2021

based on heuristic

inferred from DOI database lookup

A prognostic index for systemic AIDS-related non-Hodgkin lymphoma treated in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21759

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21759

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiretroviral treatment regimens and immune parameters in the prevention of systemic AIDS-related non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21759

7 January 2021

based on heuristic

inferred from DOI database lookup

Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy. French-Italian Cooperative Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21759

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21759

7 January 2021

based on heuristic

inferred from DOI database lookup

Saquinavir enhances the mucosal toxicity of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21759

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive Chemotherapy (LNHIV-91 Regimen) and G-CSF for HIV Associated Non-Hodgkin's Lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21759

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21759

7 January 2021

based on heuristic

inferred from DOI database lookup

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21759

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trials.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21759

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.21759

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16502436%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16502436%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q82665464&oldid=1531140461"